Erlotinib Hydrochloride in Treating Patients With Bladder Cancer Undergoing Surgery
Part of paid clinical trials in Baltimore, Maryland.
- Sponsor
- National Cancer Institute (NCI)
- Study ID
- NCT02169284
- Phase
- PHASE2
- Status
- Terminated
Conditions
- Bladder Carcinoma
- Recurrent Bladder Carcinoma
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Erlotinib Hydrochloride — DRUGGiven PO
- Laboratory Biomarker Analysis — OTHERCorrelative studies
- Pharmacological Study — OTHERCorrelative studies
- Placebo — OTHERGiven PO
- Quality-of-Life Assessment — OTHERAncillary studies
- Therapeutic Conventional Surgery — PROCEDUREUndergo TURBT or cystectomy
Study Details
This randomized phase II trial studies how well erlotinib hydrochloride works in treating patients with bladder cancer undergoing surgery. Erlotinib hydrochloride may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Key Dates
- Start date
- Oct 1, 2014
- Status verified
- Jun 2020
- Primary completion
- Mar 30, 2018
- Completion
- Mar 30, 2018
Study Design
- Enrollment
- 50 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Group I (erlotinib hydrochloride)Patients receive erlotinib hydrochloride PO QD on days 1, 8, and 15. Patients then undergo TURBT or cystectomy on day 16.
- Placebo Comparator: Group II (placebo)Patients receive placebo PO QD on days 1, 8, and 15. Patients then undergo TURBT or cystectomy on day 16.
Primary Outcome Measure
EGFR Phosphorylation in Normal Appearing Bladder Epithelium Adjacent to Tumor [ Time Frame: Up to 18 hours after last study drug dose (on day 28) ]
Locations (6)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Johns Hopkins University/Sidney Kimmel Cancer Center | Baltimore | Maryland | 21287 | - |
| Lahey Hospital and Medical Center | Burlington | Massachusetts | 01805 | - |
| University of Rochester | Rochester | New York | 14642 | - |
| Carolina Urologic Research Center | Myrtle Beach | South Carolina | 29572 | - |
| Urology San Antonio Research PA | San Antonio | Texas | 78229 | - |
| University of Wisconsin Hospital and Clinics | Madison | Wisconsin | 53792 | - |
Find similar trials in Baltimore, MD
By research site
Johns Hopkins University/Sidney Kimmel Cancer Center· Baltimore, MDLahey Hospital and Medical Center· Burlington, MAUniversity of Rochester· Rochester, NYCarolina Urologic Research Center· Myrtle Beach, SCUrology San Antonio Research PA· San Antonio, TXUniversity of Wisconsin Hospital and Clinics· Madison, WI
Related Studies
- ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy EvaluationRecruiting · Guardant Health, Inc. · Birmingham, Alabama
- A Cruciferous Vegetable Eating Program for the Reduction of Cancer Recurrence and Progression in Patients With Non-muscle Invasive Bladder CancerPHASE2 · Recruiting · Roswell Park Cancer Institute · Buffalo, New York
- Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial CancerRecruiting · University of Washington · Seattle, Washington
- Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary CancersRecruiting · City of Hope Medical Center · Duarte, California